Skip to content

Ovarian Cancer Research Alliance

OCRA Invests More Than $10.8 Million Toward Research in 2025

In 2025, OCRA invested more than $10.8 million toward scientific research — part of our $14.5 million commitment this year to strengthen the community through research, patient support, education, and advocacy.

Only OCRA combines a laser focus with a panoramic view.

Funding Breakthrough Research

OCRA has invested $137 million toward finding a cure for ovarian and gynecologic cancers.

Discover our research

Supporting You Every Step of The Way

OCRA’s groundbreaking patient support programs help more than 95,000 people each year navigate an overwhelming diagnosis, aiding patients and families when they need it most.

Find support

Advocacy is the Lifeblood of Change

OCRA advocates on Capitol Hill to improve research and education, drug and diagnostic safety, and access to quality care for all members of the ovarian and gynecologic cancer community. To date, OCRA has helped secure more than $3.8 billion in federal funding.

Take action now
A woman wearing sunglasses and a gray shirt kisses a small child on the lips. The child, dressed in a yellow shirt with a Disney character and a yellow bow in her hair, looks content. They are outdoors with trees and greenery in the background.

Genetic testing can save your life.

Knowledge is power. Genetic testing can lower your risk of ovarian and gynecologic cancers.

The power of shared experiences

Join our Staying Connected Support Series, Woman to Woman Peer Mentor Program, or online community for knowledge, connection, support, and hope.

A Message from President and CEO Audra Moran

Get Involved

Join us as we drive innovation, offer hope, and invest in groundbreaking research that saves lives.

There are so many ways to lend a hand and improve the lives of thousands of ovarian and gynecologic cancer patients and their families.

News & Updates

KVIA-TV ABC-7 Features OCRA-Funded Research Developing Nanotechnology for Ovarian Cancer Detection

KVIA-TV ABC-7 Features OCRA-Funded Research Developing Nanotechnology for Ovarian Cancer Detection

KVIA-TV ABC-7 News El Paso recently spotlighted the groundbreaking work of OCRA-funded researcher Daniel Heller, PhD of Memorial Sloan Kettering Cancer Center, whose research lab is working to develop a liquid biopsy that uses nanotechnology and artificial intelligence (AI) to detect ovarian cancer earlier. We’re developing a liquid biopsy that uses nano sensors and AI … Continued

Read more

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.